Altered Hippocampal Morphology in Unmedicated Patients with Major Depressive Illness

Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA 90095, USA.
ASN Neuro (Impact Factor: 4.02). 10/2009; 1(4). DOI: 10.1042/AN20090026
Source: PubMed


Despite converging evidence that major depressive illness is associated with both memory impairment and hippocampal pathology, findings vary widely across studies and it is not known whether these changes are regionally specific. In the present study we acquired brain MRIs (magnetic resonance images) from 31 unmedicated patients with MDD (major depressive disorder; mean age 39.2+/-11.9 years; 77% female) and 31 demographically comparable controls. Three-dimensional parametric mesh models were created to examine localized alterations of hippocampal morphology. Although global volumes did not differ between groups, statistical mapping results revealed that in MDD patients, more severe depressive symptoms were associated with greater left hippocampal atrophy, particularly in CA1 (cornu ammonis 1) subfields and the subiculum. However, previous treatment with atypical antipsychotics was associated with a trend towards larger left hippocampal volume. Our findings suggest effects of illness severity on hippocampal size, as well as a possible effect of past history of atypical antipsychotic treatment, which may reflect prolonged neuroprotective effects. This possibility awaits confirmation in longitudinal studies.

Download full-text


Available from: Paolo Brambilla,
  • Source
    • "Indeed, reduced BDNF expression has been observed in the hippocampus and prefrontal cortex of MDD and BD patients (6–8), coinciding with reduced volume of these structures (9–13), impaired spatial memory (14,15), and executive function (16,17), respectively. Interestingly, overexpression and underexpression of BDNF in different parts of the brain of mice impaired their learning and memory and precipitated depression-like behavior (18–20). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Changes in brain derived neurotrophic factor (BDNF) expression have been associated with mood disorders and cognitive dysfunction. Transgenic models that overexpress or underexpress BDNF demonstrate similar deficits in cognition and mood. We explored the hypothesis that BDNF expression is controlled by balancing the activity of BDNF promoter IV (BP4) with a negative regulatory region containing a polymorphism associated with cognitive dysfunction and mood disorders. We used comparative genomics, transgenic mouse production, and magnetofection of primary neurons with luciferase reporters and signal transduction agonist treatments to identify novel polymorphic cis-regulatory regions that control BP4 activity. We show that BP4 is active in the hippocampus, the cortex, and the amygdala and responds strongly to stimuli such as potassium chloride, lithium chloride, and protein kinase C agonists. We also identified a highly conserved sequence 21 kilobase 5' of BP4 that we called BE5.2, which contains rs12273363, a polymorphism associated with decreased BDNF expression, mood disorders, and cognitive decline. BE5.2 modulated the ability of BP4 to respond to different stimuli. Intriguingly, the rarer disease associated allele, BE5.2(C), acted as a significantly stronger repressor of BP4 activity than the more common BE5.2(T) allele. This study shows that the C allele of rs12273363, which is associated with mood disorder, modulates BP4 activity in an allele-specific manner following cell depolarization or the combined activity of protein kinase A and protein kinase C pathways. The relevance of these findings to the role of BDNF misexpression in mood disorders and cognitive decline is discussed.
    Biological psychiatry 01/2012; 71(7):618-26. DOI:10.1016/j.biopsych.2011.11.030 · 10.26 Impact Factor
  • Source
    • "Structural MRI (sMRI) have documented several brain structural changes in MDD, including amygdala, hippocampus, cingulate, orbitofrontal cortex (OFC), DLPFC and ventral prefrontal cortex (Campbell et al., 2004; Lacerda et al., 2004; Caetano et al., 2006; Monkul et al., 2007; Hamilton et al., 2008; Bearden et al., 2009; McKinnon et al., 2009). In particular, as reported in meta-analyses, MDD has been shown to be associated with the reduction of hippocampal volumes (Campbell et al., 2004; McKinnon et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent brain imaging studies have shed light on understanding the pathogenesis of mood disorders. Evidence of structural, chemical, and functional brain changes, particularly in prefrontal cortex, cingulate, and amygdala, has been revealed in major depressive disorder (MDD). Furthermore, imaging techniques have been applied to monitor the effects of antidepressants (ADs) both in the brains of healthy volunteers and MDD patients. Although with some discrepancies due to the differences in study designs and patient samples, imaging findings have shown that ADs, particularly those having effects on the serotonergic system, modulate the volumes, functions and biochemistry of brain structures, i.e. dorsolateral prefrontal cortex, anterior cingulate and amygdala, which have been demonstrated abnormal in MDD by earlier imaging studies. This paper reviews imaging studies conducted in MDD patients and healthy controls treated with different ADs.
    Progress in Neuro-Psychopharmacology and Biological Psychiatry 12/2010; 35(7):1544-52. DOI:10.1016/j.pnpbp.2010.11.040 · 3.69 Impact Factor
  • Source
    • "Abnormally small hippocampal volumes have been shown in depressed subjects by several cross sectional magnetic resonance imaging (MRI) studies (Table I; for review Campbell et al., 2004), particularly in chronic, stressed and severely ill patients (Colla et al., 2007; Kronmuller et al., 2008; McKinnon et al., 2009; Vythilingam et al., 2002; Bearden et al., 2009). Therefore, recurrent exposure to stressful events or chronicity may be involved in hippocampal shrinkage in depression (Sala et al., 2004; Videbech & Ravnkilde, 2004). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Here we briefly summarize the most consistent structural MRI studies on hippocampus in major depression and debate the effects of clinical variables on hippocampal morphology.
    Epidemiologia e psichiatria sociale 12/2010; 19(4):298-301. DOI:10.1017/S1121189X00000634 · 3.16 Impact Factor
Show more